Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia

Leukemia

Volumn 26, Issue 2, 2012, Pages 312-322

  Stevanovic S ^a   Griffioen, M ^a   Nijmeijer, B A ^b   Van Schie, M L J ^a   Stumpf, A N ^a   Rutten, C E ^a   Willemze, R ^a   Falkenburg, J H F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Amsterdam Molecular Therapeutics   (Netherlands)

Author keywords

allogeneic stem cell transplantation; donor lymphocyte infusion; Graft versus Leukemia effect; immunotherapy

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC MYELOID LEUKEMIA; DONOR LYMPHOCYTE INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HELPER CELL; HUMAN; IN VIVO STUDY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; TUMOR IMMUNITY;

EID: 84860417122     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.222     Document Type: Article

References (35)

1. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW et al. T cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
2. Barge RM, Starrenburg CW, Falkenburg JHF, Fibbe WE, Marijt EW, Willemze R. Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath 'in the bag' as T cell depletion: the Leiden experience. Bone Marrow Transplant 2006; 37: 1129-1134. (Pubitemid 43871523)
3. Collins Jr RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444. (Pubitemid 27074209)
4. Porter DL, Collins Jr RH, Hardy C, Kernan NA, Drobyski WR, Giralt S et al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000; 95: 1214-1221. (Pubitemid 30099829)
5. Madrigal JA, Arguello R, Scott I, Avakian H. Molecular histocompatibility typing in unrelated donor bone marrow transplantation. Blood Rev 1997; 11: 105-117. (Pubitemid 27321020)
6. Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ et al. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 1984; 81: 4917-4921. (Pubitemid 14066225)
7. Rutten CE, van Luxemburg-Heijs SAP, Griffioen M, Marijt EW, Jedema I, Heemskerk MHM et al. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia. Leukemia 2008; 22: 1387-1394. (Pubitemid 352006083)
8. Schoenberger SP, Toes RE, van d V, Offringa R, Melief CJ. T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40 L interactions. Nature 1998; 393: 480-483.
9. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic T cell responses is mediated by CD40 signalling. Nature 1998; 393: 478-480.
10. Ridge JP, Di RF, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998; 393: 474-478.
11. Shedlock DJ, Shen H. Requirement for CD4T cell help in generating functional CD8T cell memory. Science 2003; 300: 337-339. (Pubitemid 36433726)
12. Faber LM, van Luxemburg-Heijs SAP, Veenhof WF, Willemze R, Falkenburg JHF. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graftversus-leukemia reactivity. Blood 1995; 86: 2821-2828.
13. Kloosterboer FM, van Luxemburg-Heijs SAP, van Soest RA, Barbui AM, van Egmond HM et al. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells. Leukemia 2004; 18: 798-808. (Pubitemid 38500199)
14. Griffioen M, van der Meijden ED, Slager EH, Honders MW, Rutten CE, van Luxemburg-Heijs SAP et al. Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. Proc Natl Acad Sci USA 2008; 105: 3837-3842. (Pubitemid 351723486)
15. Nimer SD, Giorgi J, Gajewski JL, Ku N, Schiller GJ, Lee K et al. Selective depletion of CD8+ cells for prevention of graftversus-host disease after bone marrow transplantation. A randomized controlled trial. Transplantation 1994; 57: 82-87. (Pubitemid 24032744)
16. Soiffer RJ, Alyea EP, Hochberg E, Wu C, Canning C, Parikh B et al. Randomized trial of CD8+ T cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion. Biol Blood Marrow Transplant 2002; 8: 625-632. (Pubitemid 35446754)
17. Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ et al. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells. Clin Cancer Res 2002; 8: 2052-2060. (Pubitemid 34753573)
18. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
19. Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 1999; 162: 168-175. (Pubitemid 29018917)
20. Smit WM, Rijnbeek M, van Bergen CAM, de Paus RA, Vervenne HA, van de Keur M et al. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol 1997; 53: 216-223. (Pubitemid 27176477)
21. Jedema I, Meij P, Steeneveld E, Hoogendoorn M, Nijmeijer BA, van de Meent M et al. Early detection and rapid isolation of leukemia-reactive donor T cells for adoptive transfer using the IFN-gamma secretion assay. Clin Cancer Res 2007; 13 (2 Part 1): 636-643. (Pubitemid 46225371)
22. Cignetti A, Bryant E, Allione B, Vitale A, Foa R, Cheever MA. CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood 1999; 94: 2048-2055. (Pubitemid 29430421)
23. Brouwer RE, van der Hoorn MAWG, Kluin-Nelemans HC, van Zelderen-Bhola S, Willemze R, Falkenburg JHF. The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses. Hum Immunol 2000; 61: 565-574. (Pubitemid 30346483)
24. Hoogendoorn M, Wolbers JO, Smit WM, Schaafsma MR, Barge RM, Willemze R et al. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy. Leukemia 2004; 18: 1278-1287. (Pubitemid 39023139)
25. Nijmeijer BA, van Schie MLJ, Verzaal P, Willemze R, Falkenburg JHF. Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T cell responses as observed in an animal model for human leukemia. Exp Hematol 2005; 33: 1172-1181. (Pubitemid 41416965)
26. Heemskerk MHM, Hoogeboom M, de Paus RA, Kester MG, van der Hoorn MA, Goulmy E et al. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T cell receptor complexes expressing a conserved alpha joining region. Blood 2003; 102: 3530-3540. (Pubitemid 37409367)
27. Griffioen M, van Egmond HM, Barnby-Porritt H, van der Hoorn MA, Hagedoorn RS, Kester MG et al. Genetic engineering of virus-specific T cells with T cell receptors recognizing minor histocompatibility antigens for clinical application. Haematologica 2008; 93: 1535-1543.
28. Rutten CE, van Luxemburg-Heijs SAP, van der Meijden ED, Griffioen M, Oudshoorn M, Willemze R et al. HLA-DPB1 mismatching results in the generation of a full repertoire of HLADPB1 specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles. Biol.Blood Marrow Transplant 2010; 16: 1282-1292.
29. Stumpf AN, van der Meijden ED, van Bergen CAM, Willemze R, Falkenburg JHF, Griffioen M. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Blood 2009; 114: 3684-3692.
30. Rutten CE, van Luxemburg-Heijs SAP, van der Meijden ED, Griffioen M, Oudshoorn M, Willemze R et al. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro. Blood 2010; 115: 151-153.
31. Petersdorf EW. Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol 2008; 20: 588-593.
32. Petersdorf EW, Kollman C, Hurley CK, Dupont B, Nademanee A et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood 2001; 98: 2922-2929.
33. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923-1930. (Pubitemid 39297840)
34. Chalandon Y, Tiercy JM, Schanz U, Gungor T, Seger R et al. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplant 2006; 37: 909-916. (Pubitemid 43792550)
35. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, EapenM et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576-4583. (Pubitemid 351377826)